Discovery Technologies – Cellzome AG (CellZ)

Cellzome is a pioneer in the development and advancement of proteomics technologies in drug discovery. The company is applying its pathway mapping technology to the analysis of protein-protein interaction networks underlying disease pathways. Cellzome intends to apply its chemical proteomics technology to identify the affinity interactions between active lead compounds and the proteome.

Key Personnel

Gerard Drewes, Marcus Bantscheff